Academy president Janet Yang talks about diversifying membership, inspiring initiatives, and the essential value of authentic ...

Cassava Sciences (SAVA) stock gains as company strikes consulting agreement with former CEO Remi Barbier. Read more here.

Gilead Sciences Inc. closed $3.98 short of its 52-week high ($87.87), which the company achieved on January 19th.

Shares of Gilead Sciences Inc. GILD dropped 0.13% to $83.05 Tuesday, on what proved to be an all-around mixed trading session ...

SEPTEMBER 20, 2024 — Cornel Pasnicu, a professor of mathematics in the UTSA College of Sciences, passed away this summer at ...

Fintel reports that on September 19, 2024, B. Riley Securities initiated coverage of Wave Life Sciences (NasdaqGM:WVE) with a ...

Classes have resumed at the Albany College of Pharmacy and Health Sciences after their computer systems were disrupted.

The University of Iowa was approved to restructure and terminate multiple programs within the College of Liberal Arts and ...

Goldman Sachs analyst Chris Shibutani has maintained their bullish stance on ROIV stock, giving a Buy rating today. Chris Shibutani has given ...

Alzheimer’s disease is the most common form of dementia, affecting more than 6 million people in the United States alone. Despite extensive research, effective treatments remain limited, and the need ...

Advances in treatment and new drugs are pushing cancer care even farther away from hospital campuses into outpatient settings ...

Gilead Sciences (GILD) stock price has staged a strong comeback this year, helped by strong earnings and a recent $40 million ...